BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

"Ringing In The Ear" May Respond To Alcoholism Drug


10/19/2005 5:12:41 PM

A drug used to treat alcoholism can help people with tinnitus, the "ringing in the ears" that can make life miserable, Brazilian researchers report. Nearly 90 percent of a small group of people with tinnitus reported substantial relief after taking the drug acamprosate, according to otolaryngologists at the Federal University of Rio de Janeiro. "In 47.8 percent of the cases, we found relief higher than 50 percent," they noted, adding that "the incidence of side effects was low." The researchers attributed acamprosate's success to its effect on glutamate, an amino acid that stimulates activity of the nervous system. Their theory is that tinnitus is caused by disruptions in the same glutamate pathways that are involved in addiction to alcohol. Acamprosate, marketed as Campral by Lipha Pharmaceuticals, Inc. of Lyon, France, is widely used in Europe and was approved last year by the Food and Drug Administration as a treatment for alcohol dependence. The findings were to be presented at the American Academy of Otolaryngology's annual meeting, which starts Sept. 25 in Los Angeles.

Read at HealthDay
Read at WebMD

HealthDay
WebMD
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES